News About: Pharm. Industry
Pharma companies’ various measures to respond to Kim Young-Ran Law
Pharmaceutical companies have prepared for various ‘sales guidelines’ to response to the Kim Young-Ran Law which has been enforced from the 28th next month.
On a basis of exceptions(food & beverage for KRW 30 thousan...
Hanmi will sincerely exercise committee’s decision on Olita TabHanmi Pharm announced it respects the decision of the Central Drug Deliberation Committee and will sincerely exercise the safety control measure.
Previously, the Ministry of Fo...
|
Industry shocked by first imprisonment on head director of pharma company
A head director of a pharmaceutical company was sentenced imprisonment for the pharmaceutical company-doctor rebate case.
According to the industry concerned, the court was known to sentence the director, who was jai...
Former CEO of Takeda Pharmaceuticals Korea joins in IT venture as president
A company specializing in providing solutions based on smart devices, Appknot(CEO Woo-Yong Jang) announced appointment of the former president of Takeda Pharmaceuticals Korea, Choon-Yup Lee, as of the 1st of October.
...
Hanmi, “Failure experience of Olmutinib is the most valuable asset”Hanmi Pharm held a press conference related to the recent olmutinib issue on the 2nd at its head office located in Songpa-gu, Seoul, and answered to questions about Boehringer I...
|
Why did Hanmi get caught in dilemma?
Hanmi Pharm gets in the focus of controversy as being associated with the technology export of an antibody of KRW 1 trillion with Genentech while having issues with Boehringer Ingelheim which decided to return the lic...
Hanmi Pharm signs anticancer technology export of KRW 1 trillion with GenentechHanmi Pharm announced conclusion of a license agreement for the development and commercialization of HM95573, a targeted therapy under development for Phase 1 clinical trials, w...
|
GE Healthcare establishes ‘APAC Fast Track Center’ in Song-do
GE Healthcare announced it selected Korea as a biopharmaceutical hub for the Asia Pacific(APAC) region and decided to accelerate growth of the Korean biopharmaceutical industry by establishing an educational institute...
Pfizer Pharmaceuticals Korea keeps current corporate organization without divisionPfizer Pharmaceuticals Korea announced a plan to keep the current single corporate system of ‘Pfizer Pharmaceuticals Korea.’
The company revealed the Pfizer Group’s result of d...
|
Focusing on lecture & consulting fees, admin. investigation be effective to find rebates?
Mentioned at the recent National Inspection, administrative investigation on multinational pharmaceutical companies will conducted on a basis of lecture and consulting fees. A part of the industry, however, has a skep...
